| __timestamp | Celldex Therapeutics, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 24518692 |
| Thursday, January 1, 2015 | 33837000 | 19886580 |
| Friday, January 1, 2016 | 35979000 | 12631689 |
| Sunday, January 1, 2017 | 25003000 | 21977998 |
| Monday, January 1, 2018 | 19269000 | 20759000 |
| Tuesday, January 1, 2019 | 15426000 | 20838000 |
| Wednesday, January 1, 2020 | 14456000 | 121812000 |
| Friday, January 1, 2021 | 20488000 | 152137000 |
| Saturday, January 1, 2022 | 27195000 | 83231000 |
| Sunday, January 1, 2023 | 30914000 | 122706000 |
Infusing magic into the data realm
In the competitive world of biotechnology, managing expenses is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of TG Therapeutics, Inc. and Celldex Therapeutics, Inc. from 2014 to 2023. Over this period, TG Therapeutics saw a dramatic increase in SG&A expenses, peaking at approximately 152 million in 2021, a staggering 500% rise from 2016. In contrast, Celldex Therapeutics maintained a more stable expense pattern, with a modest 50% increase from 2014 to 2023. This divergence highlights TG Therapeutics' aggressive expansion strategy, while Celldex appears to focus on steady growth. Understanding these trends provides valuable insights into each company's operational strategies and market positioning. As the biotech industry continues to evolve, monitoring such financial metrics will be key to predicting future success.
Breaking Down SG&A Expenses: Johnson & Johnson vs TG Therapeutics, Inc.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs TG Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and Celldex Therapeutics, Inc.
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Madrigal Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cytokinetics, Incorporated or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of TG Therapeutics, Inc. and MorphoSys AG
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or Agios Pharmaceuticals, Inc.
TG Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Bausch Health Companies Inc. and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
Celldex Therapeutics, Inc. or Evotec SE: Who Manages SG&A Costs Better?